BSE Live
Dec 08, 09:17Prev. Close
1823.95
Open Price
1842.95
Bid Price (Qty.)
1828.85 (3)
Offer Price (Qty.)
1835.30 (5)
NSE Live
Dec 08, 09:17Prev. Close
1825.40
Open Price
1837.50
Bid Price (Qty.)
1829.00 (4)
Offer Price (Qty.)
1832.60 (28)
| Balance Sheet of JB Chemicals and Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 15.57 | 15.52 | 15.48 | 15.46 | 15.46 | |
| Total Share Capital | 15.57 | 15.52 | 15.48 | 15.46 | 15.46 | |
| Reserves and Surplus | 3,361.63 | 2,870.74 | 2,305.38 | 2,025.56 | 1,791.00 | |
| Total Reserves and Surplus | 3,361.63 | 2,870.74 | 2,305.38 | 2,025.56 | 1,791.00 | |
| Total Shareholders Funds | 3,377.19 | 2,886.26 | 2,442.45 | 2,103.67 | 1,806.46 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 23.64 | 383.22 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 186.25 | 154.54 | 106.58 | 51.92 | 63.77 | |
| Other Long Term Liabilities | 7.82 | 9.81 | 15.23 | 21.92 | 10.07 | |
| Long Term Provisions | 22.19 | 18.33 | 14.61 | 13.22 | 12.57 | |
| Total Non-Current Liabilities | 216.26 | 206.32 | 519.64 | 87.06 | 86.41 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 318.16 | 143.71 | 26.32 | 26.43 | |
| Trade Payables | 384.58 | 331.65 | 221.71 | 196.24 | 164.02 | |
| Other Current Liabilities | 140.67 | 124.55 | 104.27 | 83.50 | 92.49 | |
| Short Term Provisions | 59.18 | 46.70 | 38.34 | 41.29 | 24.62 | |
| Total Current Liabilities | 584.44 | 821.06 | 508.03 | 347.34 | 307.56 | |
| Total Capital And Liabilities | 4,177.90 | 3,913.64 | 3,470.15 | 2,538.07 | 2,200.43 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 606.60 | 567.23 | 526.63 | 548.54 | 542.27 | |
| Intangible Assets | 1,276.69 | 1,358.19 | 1,295.03 | 655.13 | 22.33 | |
| Capital Work-In-Progress | 45.96 | 63.32 | 44.41 | 13.91 | 25.57 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 1,944.99 | 2,001.48 | 1,876.81 | 1,222.34 | 590.17 | |
| Non-Current Investments | 170.86 | 166.58 | 146.75 | 145.69 | 145.88 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.35 | 0.58 | 0.68 | 0.74 | 5.19 | |
| Other Non-Current Assets | 283.04 | 29.59 | 47.60 | 16.98 | 1.25 | |
| Total Non-Current Assets | 2,399.24 | 2,198.24 | 2,071.85 | 1,385.75 | 742.49 | |
| CURRENT ASSETS | ||||||
| Current Investments | 317.11 | 364.65 | 192.18 | 0.00 | 664.97 | |
| Inventories | 471.64 | 461.20 | 386.95 | 349.78 | 278.91 | |
| Trade Receivables | 768.09 | 624.78 | 523.58 | 518.05 | 374.11 | |
| Cash And Cash Equivalents | 90.57 | 63.70 | 55.76 | 39.67 | 26.43 | |
| Short Term Loans And Advances | 0.55 | 0.70 | 0.77 | 0.75 | 1.65 | |
| OtherCurrentAssets | 130.71 | 200.38 | 239.06 | 244.06 | 111.87 | |
| Total Current Assets | 1,778.65 | 1,715.40 | 1,398.30 | 1,152.31 | 1,457.94 | |
| Total Assets | 4,177.90 | 3,913.64 | 3,470.15 | 2,538.07 | 2,200.43 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1,165.42 | 1,110.90 | 148.86 | 68.13 | 117.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 375.18 | 381.00 | 549.99 | 214.26 | 179.21 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 1,302.39 | 1,315.08 | 1,278.42 | 894.33 | 908.22 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 8.46 | 8.46 | 8.46 | 8.46 | 8.46 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 170.86 | 166.58 | 146.75 | 145.69 | 145.88 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 317.11 | 364.65 | -- | -- | 664.97 | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
17.11.2025
JB Chemicals Consolidated September 2025 Net Sales at Rs 1,084.90 crore, up 8.42% Y-o-Y
12.11.2025
JB Chemicals Standalone September 2025 Net Sales at Rs 1,022.65 crore, up 7% Y-o-Y
31.07.2025
JB Chemicals Consolidated June 2025 Net Sales at Rs 1,093.94 crore, up 8.91% Y-o-Y
31.07.2025
JB Chemicals Standalone June 2025 Net Sales at Rs 1,039.90 crore, up 9.2% Y-o-Y
12.02.2014